M
Michael B. Lensing
Researcher at Oslo University Hospital
Publications - 11
Citations - 1206
Michael B. Lensing is an academic researcher from Oslo University Hospital. The author has contributed to research in topics: Attention deficit hyperactivity disorder & Quality of life. The author has an hindex of 7, co-authored 11 publications receiving 987 citations.
Papers
More filters
Journal ArticleDOI
European consensus statement on diagnosis and treatment of adult ADHD: The European Network Adult ADHD.
Sandra J J Kooij,Susanne Bejerot,Andrew D. Blackwell,Hervé Caci,Miquel Casas-Brugue,Pieter Jan Carpentier,Dan Edvinsson,John Fayyad,Karin Foeken,Michael Fitzgerald,Veronique Gaillac,Ylva Ginsberg,Chantal Henry,Johanna Krause,Michael B. Lensing,Iris Manor,Helmut Niederhofer,Carlos Nunes-Filipe,Martin D. Ohlmeier,P. Oswald,Stefano Pallanti,Artemios Pehlivanidis,Josep Antoni Ramos-Quiroga,Maria Råstam,Doris Ryffel-Rawak,Steven Stes,Philip Asherson +26 more
TL;DR: This Consensus Statement is one of the actions taken by the European Network Adult ADHD in order to support the clinician with research evidence and clinical experience from 18 European countries in which ADHD in adults is recognised and treated.
Journal ArticleDOI
Updated European Consensus Statement on Diagnosis and Treatment of Adult ADHD
J.J.S. Kooij,Denise Bijlenga,Luana Salerno,R. Jaeschke,István Bitter,Judit Balazs,Johannes Thome,Geert Dom,Siegfried Kasper,C. Nunes Filipe,S. Stes,Pavel Mohr,Sami Leppämäki,Miguel Casas,Julio Bobes,Jane McCarthy,V. Richarte,A. Kjems Philipsen,Artemios Pehlivanidis,Asko Niemelä,B. Styr,Bengi Semerci,Blanca Bolea-Alamanac,D. Edvinsson,D. Baeyens,Dora Wynchank,E. Sobanski,Alexandra Philipsen,Fiona McNicholas,Hervé Caci,Ilinca Mihailescu,Iris Manor,Iuliana Dobrescu,T. Saito,Johanna Krause,John Fayyad,Josep Antoni Ramos-Quiroga,K. Foeken,Florina Rad,Marios Adamou,Martin D. Ohlmeier,Michael Fitzgerald,Michael Gill,Michael B. Lensing,N. Motavalli Mukaddes,P. Brudkiewicz,Peik Gustafsson,Pekka Tani,P. Oswald,Pieter-Jan Carpentier,P. De Rossi,Richard Delorme,S. Markovska Simoska,Stefano Pallanti,S. Young,Susanne Bejerot,T. Lehtonen,James Kustow,U. Müller-Sedgwick,Tatja Hirvikoski,V. Pironti,Ylva Ginsberg,Z. Félegyházy,M.P. García-Portilla,P. Asherson +64 more
TL;DR: This Updated European Consensus Statement aims to support clinicians with research evidence and clinical experience from 63 experts of European and other countries in which ADHD in adults is recognized and treated, to increase awareness and knowledge of adult ADHD in and outside Europe.
Journal ArticleDOI
Quality of Life in Adults Aged 50+ With ADHD
TL;DR: The negative impact of ADHD persists into late adulthood, and adults aged 50+ with ADHD diagnosed in late adulthood reported significantly reduced quality of life when compared with population norms.
Journal ArticleDOI
Four-year outcome in psychopharmacologically treated adults with attention-deficit/hyperactivity disorder: a questionnaire survey.
TL;DR: In adults with ADHD, pharmacologic treatment for more than 2 years was associated with better functioning than treatment for 2 years or less andComorbidity at baseline predicted poorer outcome than did no comorbid illness.
Journal ArticleDOI
Optimal management of ADHD in older adults.
TL;DR: It is suggested that many patients aged ≥50 years experience beneficial effects of pharmacological treatment, and individualized therapy for each elderly patient should be recommended to balance risk–benefit ratio when pharmacotherapy is considered to be a possible treatment.